October 17, 2012 08:00 ET

Free Reports on ISIS Pharmaceuticals, Pandora, First Solar and Fossil Provided by the Bedford Report

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the CAPITAL NEWS CIRCUIT

NEW YORK, NY--(Marketwire - Oct 17, 2012) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford has been an essential resource for hundreds of thousands of investors across the country.

ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS) shares fell nearly 20 percent Tuesday after a FDA committee linked the company's cholesterol drug Kynamro to both benign and cancerous tumors.

Find out more about ISIS Pharmaceuticals including full access to the free equity report at:

Pandora Media Inc. (NYSE: P) shares dipped earlier this week after Microsoft announced their new music service Xbox music. Xbox Music will include a "Smart DJ" feature which is similar to Pandora's Music Genome Project.

Find out more about Pandora including full access to the free equity report at:

First Solar, Inc. (NASDAQ: FSLR) shares surged after announcing it had signed an agreement with PJB Services to develop 100 megawatts of utility-scale solar power plants in Indonesia.

Find out more about First Solar including full access to the free equity report at:

Fossil, Inc. (NASDAQ: FOSL) shares spiked after a Citigroup analyst upgraded the company's to "buy" and set a price target of $100. 

Find out more about Fossil including full access to the free equity report at:

This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid Capital News Circuit one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Certain information included may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. However, no representation, expressed or implied, is made as to the accuracy, completeness or correctness. We accept no liability for any losses arising from an investor's reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.

Contact Information